Pharmafile Logo
Pharmafocus logo
Advanced Search
gardasil_9

CHMP recommends Sanofi’s two-dose schedule HPV vaccine

March 3, 2016
Research and Development HPV vaccine, MSD, Sanofi Pasteur

Sanofi Pasteur’s and MSD’s vaccine against human papillomavirus (HPV), Gardasil 9, has received a positive opinion from the European Medicine …

News
novo_nordisk

Novo says diabetes drug Xultophy cost-effective versus insulin intensification treatment

March 2, 2016
Sales and Marketing Novo Nordisk, Xultophy, diabetes

Novo Nordisk says findings show its Tresiba and Victoza combo Xultophy (insulin degludec/liraglutide: IDegLira), is cost-effective compared to insulin intensification …

News
nda_group_appointment

Bill Griffiths joins NDA group as general manager UK

March 2, 2016
Medical Communications NDA Group

Industry veteran Bill Griffiths has joined NDA Group to head up the company’s UK consulting team and NDA’s advisory board.  …

Appointment
gilead-sciences

FDA approves Gilead’s Odefsey for treatment of HIV-1 infection

March 2, 2016
Research and Development, Sales and Marketing Gilead Sciences, HIV, Odefsey

Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved its TAF-based single tablet regimen Odefsey …

News
janssen_latest_logo_on_sign

Janssen slams NICE decision on Imbruvica

March 2, 2016
Research and Development, Sales and Marketing CLL, Cancer, Cancer Drugs Fund, Janssen, Johnson & Johnson, NICE, imbruvica

Janssen, the R&D arm of pharma major Johnson & Johnson, says it is extremely disappointed following regulator NICE’s announcement that …

News
humira_abbott_

Top 10 medicines issued in England by prescription cost in 2014-15

March 2, 2016
Research and Development, Sales and Marketing Cost, Humira, NHS, prescription

AbbVie, Humira (adalimumab), £371m. This drug treats a variety of conditions including psoriatic arthritics, Crohn’s disease and ulcerative colitis. The …

Feature
hilary_clinton_speaks_at_a_rally_in_des_moines_in_january

Clinton steps up attacks on Valeant in latest campaign advert

March 2, 2016
Research and Development, Sales and Marketing Hilary Clinton, Valeant

This is not the first time the pharma industry has drawn the ire of the US presidential hopefuls, but Hilary …

News

LEO Pharma UK/Ireland appoints new dermatology director

March 2, 2016
Medical Communications, Sales and Marketing

LEO Pharma has appointed Michael Hinchy as dermatology director with responsibility for its UK/Ireland affiliate. Michael brings over 16 years …

Appointment
chi_med

Chi-Med starts Phase II trial for thyroid cancer drug

March 2, 2016
Research and Development Chi-Med

Hutchison China MediTech (Chi-Med) says its unit Hutchison MediPharma (HMP) has initiated mid-stage trials for sulfatinib to treat differentiated thyroid …

News
graff_ferring

Ferring names Aaron Graff CEO of US holding company

March 2, 2016
Medical Communications

Swiss fertility treatment company Ferring Pharmaceuticals on Tuesday named Aaron Graff the chief executive of its US unit, Ferring Holding. …

Appointment
merck_innovation_centre

Merck begins late-stage trials of Humira biosimilar

March 2, 2016
Research and Development, Sales and Marketing AbbVie, Humira, Merck, biosimilars

Merck has announced the beginning of a global phase III study of its Humira (adalimumb) biosimilar, MSB11022, in chronic plaque …

News

Wave expands team with new appointments

March 1, 2016
Medical Communications

Medical education specialist, Wave, has made five new appointments, which the company says reflects the growth in its business over …

Appointment
ipsen_logo

Exelixis signs $200 million licensing deal for cancer drug

March 1, 2016
Research and Development, Sales and Marketing Cancer, Cometriq, Exelixis, ipsen

Exelixis has signed a licensing agreement with French biotech firm Ipsen for its cancer drug Cometriq (cabozantinib) for an upfront …

News
celgene_1_02

Two Celgene cancer drugs approved in Ireland

March 1, 2016
Research and Development, Sales and Marketing Abraxane, Cancer, Celgene, Revlimid, imnovid

Irish regulators have recommended two cancer treatments from Celgene: Imnovid (pomalidomide), in combination with dexamethasone, for previously-treated relapsed and refractory …

News
drugs_generic

Delivering successful new drugs

March 1, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, patents, pharma

Pharma companies are struggling with challenges specific to their industry. Patents for many drugs, that had created massive amounts of …

Feature

The future for pharma packaging

March 1, 2016
Manufacturing and Production distribution, packaging, research, supply chain

The pharmaceutical packaging market is projected for strong growth through 2020, driven by innovation for new products and materials and …

Feature
lupin_pharma_logo

Lupin to set up manufacturing plant in Japan

March 1, 2016
Manufacturing and Production Japan, Lupin, manufacturing

Indian drugmaker Lupin is, via its Japanese unit Kyowa, setting up a manufacturing unit in Japan as part of its …

News
alzheimers

South Florida Uni begins £875,000 dementia drug research programme

March 1, 2016
Manufacturing and Production, Research and Development Alzheimer's

Funding from a consortium worth £875,000 pounds has helped kick start a new dementia drug research program at the University …

News
astellas

Japan approves Astellas hyperphosphatemia drug

March 1, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Hyperphosphatemia, Japan, Kiklin

Astellas Pharma has received approval from the Ministry of Health, Labour and Welfare in Japan for a supplemental new drug …

News
valeant_logo_on_board

Valeant shares slide on SEC investigation announcement

March 1, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Philidore, Valeant, regulation

Shares at troubled Valeant plummeted some 20% Monday after the company said it was under investigation by the Securities and …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026